Detalles de la búsqueda
1.
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Antimicrob Agents Chemother
; 60(1): 628-31, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503650
2.
Discovery and Structure-Activity Relationship of Cadazolid: A First-In-Class Quinoxolidinone Antibiotic for the Treatment of Clostridioides difficile Infection.
J Med Chem
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753983
3.
Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration.
J Med Chem
; 63(1): 88-102, 2020 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31804829
4.
Discovery of Novel Inhibitors of LpxC Displaying Potent in Vitro Activity against Gram-Negative Bacteria.
J Med Chem
; 63(1): 66-87, 2020 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31804826
5.
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.
J Med Chem
; 60(9): 3776-3794, 2017 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28406300
6.
Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram positive activity and improved safety profile.
J Med Chem
; 58(2): 927-42, 2015 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-25494934
7.
Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.
J Med Chem
; 56(18): 7396-415, 2013 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23968485
Resultados
1 -
7
de 7
1
Próxima >
>>